Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hinton

Showing results (151-160 of 152) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 152 results.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Journal of Medicinal Chemistry|May 5, 2026
Discovery of MK-1088 as a Potent A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Dual-Antagonist for Cancer ImmunotherapyYonglian Zhang, Elisabeth Hennessy, Matthew A Larsen, et al.
Pageof 16

Showing results (151-160 of 152) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 152 results.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Journal of Medicinal Chemistry|May 5, 2026
Discovery of MK-1088 as a Potent A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Dual-Antagonist for Cancer ImmunotherapyYonglian Zhang, Elisabeth Hennessy, Matthew A Larsen, et al.
Pageof 16